Control of somatostatin (SS) secretion by CCK-1 and CCK-2 receptors' occupation in RIN-14B cells, a rat pancreatic islet cell line

Pancreas

Volumn 39, Issue 2, 2010, Pages 127-134

  El Kouhen, Karim ^a   Morisset, Jean ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

CCK receptor subtypes; Secretion; Somatostatin

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; BREFELDIN A; CERULETIDE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CYCLOHEXIMIDE; L 364178; N TERT BUTYLOXYCARBONYLCHOLECYSTOKININ[27-32][28,31 NORLEUCINE] PHENETHYL ESTER; PENTAGASTRIN; SOMATOSTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL LINE; CELL MIGRATION; CELL POPULATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HORMONE RELEASE; HORMONE SYNTHESIS; IMMUNOFLUORESCENCE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN FOLDING; RAT; RIN 143;

EID: 77649249880     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bea475     Document Type: Article

References (48)

1. Sakamoto C, Goldfine ID, Roach E, et al. Localization of saturable CCK binding sites in rat pancreatic islets by light and electron microscope autoradiography. Diabetes. 1985;34:390-394.
2. Schweiger M, Erhard MH, Amselgruber WM. Cell-specific localization of the cholecystokinin A receptor in the porcine pancreas. Anat Histol Embryol. 2000;29:357-361.
3. Morisset J, Wong H, Walsh JH, et al. Pancreatic CCKB receptors: their potential roles in somatostatin release and C cell proliferation. Am J Physiol. 2000;279:G148-G156.
4. Morisset J, Julien S, Lainé J. Localization of cholecystokinin receptor subtypes in the endocrine pancreas. J Histochem Cytochem. 2003;51: 1501-1513. (Pubitemid 37444538)
5. Larsson LI, Rehfeld JF. Evidence for a common evolutionary origin of gastrin and cholecystokinin. Nature. 1977;269:335-338.
6. Rehfeld JF. Four basic characteristics of the gastrin-cholecystokinin system. Am J Physiol. 1981;240:G255-G266.
7. Dockray GJ, Varro A, Dimaline R, et al. The gastrins: their production and biological activities. Ann Rev Physiol. 2001;63:119-139.
8. Hershey SJ, Sachs G. Gastric acid secretion. Physiol Rev. 1995;75: 155-189.
9. Wank SA, Pisegna JR, deWeerth A. Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci U S A. 1992;89:8691-8695.
10. Wank SA, Harkins R, Jensen RT, et al. Purification, molecular cloning and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci U S A. 1992;89:3125-3129.
11. Wank SA. Cholecystokinin receptors. Am J Physiol. 1995;269: G628-G646.
12. Stark HA, Sharp CM, Sutliff VE, et al. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low affinity cholecystokinin receptors. Biochim Biophys Acta. 1989;1010: 145-150.
13. Chang RS, Lotti VJ. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc Natl Acad Sci U S A. 1986;83:4923-4926.
14. Lotti VJ, Chang RS. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260. Eur J Pharmacol. 1989;162:273-280.
15. Jensen RT, Lemp GF, Gardner JD. Interaction of cholecystokinin with specific membrane receptors on pancreatic acinar cells. Proc Natl Acad Sci U S A. 1980;77:2079-2083.
16. Sankaran H, Goldfine ID, Deveney CW, et al. Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem. 1980;255:1849-1853.
17. Matozaki T, Martinez J, Williams JA. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini. Am J Physiol. 1989;257:G594-G600.
18. Verspohl EJ, Ammon HP, Williams JA, et al. Evidence that cholecystokinin interacts with specific receptors and regulates insulin release in isolated rat islets of Langerhans. Diabetes. 1986;35:38-43.
19. Rassetti L, Shulman GI, Zawalich WS. Physiological role of cholecystokinin in meal induced insulin secretion in conscious rats. Studies with L-364,718, a specific inhibitor of CCK-receptor binding. Diabetes. 1987;36:1212-1215.
20. Hermansen K. Effects of cholecystokinin (CCK)-4, nonsulfated CCK-8, and sulfated CCK-8 on pancreatic somatostatin, insulin, and glucagon secretion in the dog: studies in vitro. Endocrinology. 1984;114:1770-1775.
21. Rehfeld JF, Larsson LI, Goltermann NR, et al. Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature. 1980;284:33-38.
22. Zavros Y, Shulkes A. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep. J Physiol. 1997;505:811-821.
23. Lloyd KCK, Maxwell V, Chuang CN, et al. Somatostatin is released in response to cholecystokinin by activation of type A CCK receptors. Peptides. 1994;15:223-227.
24. Ipp E, Dobbs RE, Harris V, et al. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. J Clin Invest. 1977;60:1216-1219.
25. El-Kouhen K, Morisset J. Cholecystokinin and somatostatin negatively affect growth of the somatostatin-RIN-14B cells. Int J Endocrinol. 2009; Vol 2009, Article ID 875167, 6 pages. DOI: 10.1155/2009/875167.
26. Gazdar AF, Chick WL, Oie HK, et al. Continuous, clonal, insulin and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci U S A. 1980;77:3519-3523.
27. Wang F, Adrian TE, Westermark GT, et al. Islet amyloid polypeptide totally inhibits A, >, and C-cell secretion in isolated rat pancreatic islets. Am J Physiol. 1999;276:E19-E24.
28. Bhathena SJ, Awoke S, Voyles NR, et al. Insulin, glucagon, and somatostatin secretion by cultured rat islet cell tumor and its clones. Proc Soc Exp Biol Med. 1984;175:35-38.
29. Scemama JL, DeVries L, Pradayrol L, et al. Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line. Am J Physiol. 1989;256:G846-G850.
30. Weinberg DS, Ruggeri B, Barber MT, et al. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest. 1997;100:597-603.
31. Reubi JC, Schaer JC, Waser B. Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 1997;57: 1377-1386.
32. Solomon TE, Morisset J, Wood JG, et al. Additive interaction of pentagastrin and secretin on pancreatic growth in rats. Gastroenterology. 1987;92:429-435.
33. Lherisson C, Estival A, Pradayrol L, et al. HPLC analysis of somatostatin peptides secreted by a rat pancreatic endocrine cell line (RINT3): stimulation studies. Horm Res. 1989;32:67-70.
34. Patel YC, Papachristou DN, Zingg HH, et al. Regulation of islet somatostatin secretion and gene expression: selective effects of adenosine 3¶,5¶-monophosphate and phorbol esters in normal islets of Langerhans and in a somatostatin-producing rat islet clonal cell line 1027 B2. Endocrinology. 1991;128:1754-1762.
35. Ennis HL, Lubin M. Cycloheximide: aspects of inhibition of protein synthesis in mammalian cells. Science. 1964;146:1474-1476.
36. Jackson CL. Brefeldin A revealing the fundamental principles governing membrane dynamics and protein transport. Subcell Biochem. 2000;34:233-272.
37. Morisset J. The gastrointestinal cholecystokinin receptors in health and diseases. Annales Academiae Medicae Bialostocensis. 2005;50: 21-36.
38. Saillan-Barreau C, Clerc P, Adato M, et al. Transgenic CCK-B/gastrin receptor mediates murine exocrine secretion. Gastroenterology. 1998;115:988-996.
39. Ji B, Bi Y, Simeone D, et al. Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology. 2001;121:1380-1390.
40. McWilliams DF, Watson SA, Crossbee DM, et al. Coexpression of gastrin and gastrin receptors (CCK-B and $CCK-B) in gastrointestinal tumour cell lines. Gut. 1998;42:795-798.
41. Blackmore M, Hirst BH. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br J Cancer. 1992;66:32-38.
42. Douziech N, Lajas A, Coulombe Z, et al. Growth effect of regulatory peptides and intracellular signaling routes in human pancreatic cell lines. Endocrine. 1998;9:171-183.
43. Larsson LI, Rehfeld JF, Goltermann N. Gastrin in the human fetus. Distribution and molecular forms of gastrin in the antro-pyloric gland area, duodenum and pancreas. Scand J Gastroenterol. 1977;12: 869-872.
44. Thorens B, Gerard N, Deriaz N. GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic B-cells and insulinoma: evidence for a block in trans-Golgi network by brefeldin A. J Cell Biol. 1993;123:1687-1694.
45. Rothman JE, Orci L. Molecular dissection of the secretory pathway. Nature. 1992;355:409-415.
46. Verchere CB, D'Alessio DA, Prigeon RL, et al. The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes. 2000;49: 1477-1484.
47. Daull P, HomeW, Boileau G, et al. Brefeldin A-induced prosomatostatin N-glycosylation in AtT20 cells. Biochem Biophys Res Commun. 2002;296:618-624.
48. Shimizu K, Kato Y, Shiratori K, et al. Evidence for the existence of CCK-producing cells in rat pancreatic islets. Endocrinology. 1998;139: 389-396.